Strategic Alliances

As we focus on realizing the potential value of cabozantinib, our multiple strategic alliances create near-, mid-, and long-term opportunities for generating additional revenue from our portfolio of novel compounds. These alliances cover a variety of proprietary small molecule compounds with potential in the treatment of cancer and metabolic diseases. Revenue generated through these alliances provides financial support for our ongoing efforts to commercialize and expand the market potential of cabozantinib.